CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)	12 Months Ended
	Dec. 31, 2024	Dec. 31, 2023	Dec. 31, 2022
Cash flows from operating activities:
Net income (loss)	$ 94,805,484	$ (43,423,715)	$ (432,739,618)
Adjustment to reconcile net income (loss) to net cash from operating activities:
Depreciation and amortization	18,971,972	17,591,572	13,131,374
Impairment of assets	3,887,216	29,082,203	0
Impairment of goodwill	3,197,391	1,139,297	398,135,038
Derecognition of goodwill	453,017	0	0
Loss on warrant liability	1,608,973	0	0
Stock-based compensation expense	16,554,898	2,835,971	189,581
Rescission of warrant exercise expense	0	0	561,651
Deferred tax (benefit) expense	(13,132,990)	(5,707,323)	4,996,209
Debt accretion expense	1,042,663	1,209,981	1,952,829
Loss on lease termination	0	58,210	0
Non-cash lease expense	(381,035)	131,582	64,143
Changes in operating assets and liabilities:
Inventories	540,770	142,701	(719,107)
Prepaid expenses and other current assets	(7,021,010)	(817,297)	(1,419,139)
Accrued arbitration expenses	47,741,815	0	0
Accrued income tax expense	26,532,699	0	0
Accrued expenses and other current liabilities	12,478,227	5,845,481	(1,311,865)
Net cash from operating activities	23,153,807	1,256,452	50,607,108
Cash flows from investing activities:
Acquisitions of property and equipment	(2,303,897)	(9,496,832)	(14,632,414)
Purchase of restricted short-term investment	(2,940,796)	0	0
Acquired cash in reverse acquisition with Clinigence	0	0	12,716,228
Cash related to sale of business	(361,325)	0	0
Payments for acquisitions of businesses, net of cash acquired	0	(703,893)	0
Cash related to deconsolidation of Real Estate Entities	0	(1,039,157)	(2,421,212)
Net cash from investing activities	(5,606,018)	(11,239,882)	(4,337,398)
Cash flows from financing activities:
Proceeds from lines of credit	2,261,743	2,340,911	2,623,479
Proceeds from notes payable	7,014,999	16,952,905	815,881
Proceeds from convertible notes	0	4,909,864	0
Repayments of lines of credit	(2,079,390)	(1,592,714)	(72,055)
Repayments of notes payable	(9,969,391)	(16,479,512)	(7,237,094)
Repayments of finance leases	(4,628,083)	(3,484,683)	(1,721,224)
Proceeds from common stock issuance, net issuance costs	9,202,500	0	0
Rescission of warrant exercise	0	0	(588,042)
Proceeds from exercise of warrants	2,373,336	0	4,119,141
Proceeds from exercise of options	0	0	644,974
Members' contributions	3,353,023	298,032	4,513,867
Members' distributions	(6,437,966)	(5,214,581)	(51,231,657)
Net cash from financing activities	1,090,771	(2,269,778)	(48,132,730)
Net change in cash and cash equivalents and restricted cash	18,638,560	(12,253,208)	(1,863,020)
Cash and cash equivalents and restricted cash - beginning of the year	22,002,056	34,255,264	36,118,284
Cash and cash equivalents and restricted cash - end of the year	40,640,616	22,002,056	34,255,264
Nonrelated Party
Changes in operating assets and liabilities:
Accounts receivable	(173,956,924)	(969,761)	56,622,133
Accounts payable	(8,682,179)	(4,715,101)	10,018,100
Related Party
Changes in operating assets and liabilities:
Accounts receivable	549,879	(3,613,885)	1,454,934
Accounts payable	$ (2,037,059)	$ 2,466,536	$ (329,155)